Cargando…
Oxidized-LDL Deteriorated the Renal Residual Function and Parenchyma in CKD Rat through Upregulating Epithelial Mesenchymal Transition and Extracellular Matrix-Mediated Tubulointerstitial Fibrosis—Pharmacomodulation of Rosuvastatin
This study tested the hypothesis that intrarenal arterial transfusion of oxidized low-density lipoprotein (ox-LDL) jeopardized the residual renal function and kidney architecture in rat chronic kidney disease ((CKD), i.e., induced by 5/6 nephrectomy) that was reversed by rosuvastatin. Cell culture w...
Autores principales: | Sung, Pei-Hsun, Cheng, Ben-Chung, Hsu, Tsuen-Wei, Chiang, John Y, Chiang, Hsin-Ju, Chen, Yi-Ling, Yang, Chih-Chao, Yip, Hon-Kan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774560/ https://www.ncbi.nlm.nih.gov/pubmed/36552673 http://dx.doi.org/10.3390/antiox11122465 |
Ejemplares similares
-
Intravenous administration of iPS‐MSC(SPIONs) mobilized into CKD parenchyma and effectively preserved residual renal function in CKD rat
por: Sheu, Jiunn‐Jye, et al.
Publicado: (2020) -
Pharmacomodulation of a ligand targeting the HBV capsid hydrophobic pocket
por: Briday, Mathilde, et al.
Publicado: (2022) -
Comparative pharmacology of oral fluoropyrimidines: a focus on pharmacokinetics, pharmacodynamics and pharmacomodulation
por: Milano, G, et al.
Publicado: (2004) -
Pharmacomodulation of microRNA Expression in Neurocognitive Diseases: Obstacles and Future Opportunities
por: Simion, Viorel, et al.
Publicado: (2017) -
Autosomal Dominant Tubulointerstitial Kidney Disease: An Emerging Cause of Genetic CKD
por: Econimo, Laura, et al.
Publicado: (2022)